Clinical Results of Tenofovir Disoproxil Fumarate in a Hemodialysis Patient with Chronic Hepatitis B

A male hepatitis B virus (HBV) carrier in his 40s under hemodialysis treatment exhibited chronic hepatitis (alanine aminotransferase: 41 IU/L, HBV-DNA: >9.1 log copies/mL). Following discontinuation of the initial treatment with pegylated interferon-α-2a at 24 weeks due to adverse effects, the ad...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Case Reports in Nephrology and Dialysis 2020-09, Vol.10 (3), p.130-138
Hauptverfasser:	Aomura, Daiki, Tachibana, Naoki, Komatsu, Michiharu, Kobayashi, Masakazu
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Antiretroviral drugs Care and treatment Case Report Case reports Case studies chronic hepatitis b Chronic kidney failure Drug resistance Drug therapy end-stage renal disease Hemodialysis Hemodialysis patients Hepatitis Hepatitis B Infections Kidney diseases Liver cancer Mortality nucleoside analogue Patient outcomes Patients Serology Tenofovir tenofovirdisoproxil fumarate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!